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Biochemical markers of bone metabolism during early orthodontic tooth
movement with aligners
Tommaso Castroflorioa; Eugenio F. Gamerrob; Gian Paolo Cavigliac; Andrea Deregibusd
ABSTRACT
Objective: To evaluate the expression of receptor activator of nuclear factor-kappa ligand
(RANKL), osteoprotegerin (OPG), osteopontin (OPN), interleukin 1b (IL-1b), and transforming
growth factor ß1 (TGF-ß1) in the gingival crevicular fluid (GCF) of teeth subjected to orthodontic
forces released by aligners.
Materials and Methods: A total of 10 healthy, adult patients were selected to participate in this
split-mouth study. The treatment plan was designed to obtain only one movement with the first
aligner: distalization of a second molar. GCF samples were obtained from pressure and tension
sites of the test tooth and from the mesiobuccal and distobuccal sites of the control tooth. The GCF
sample volumes were measured using a Periotron 8000. Levels of TGF-b, IL-1b, RANKL, OPG,
and OPN were measured by enzyme-linked immunosorbent assay.
Results: IL-1b showed a significant increase at the pressure sites after 1 week and 3 weeks with
respect to baseline (P , .05) compared with control sites. The kinetics of TGF-1b and OPN were
characterized by a significant increase at the tension sites of the test teeth (P , .05) after 3 weeks
from the application of orthodontic force. The RANKL level was significantly increased at pressure
and tension sites after 1 hour and after 1 week from the application of the orthodontic forces (P¼
.023 and P ¼ .043, respectively).
Conclusions: An increased concentration of bone modeling and remodeling mediators at the
pressure sites (IL-1b, RANKL) and tension sites (TGF-1b, OPN) was observed. These scenarios
are compatible with previous in vivo and in vitro studies investigating the biological effects of
orthodontic tooth movement. (Angle Orthod. 2017;87:74–81)
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INTRODUCTION
The application of an orthodontic force produces a
tissue reaction resulting from the perturbation gener-
ated by the orthodontic appliance and the modeling
and remodeling of the alveolar bone.1
Aligners provide intermittent orthodontic forces and,
despite their spread among the orthodontic community,
there are no studies describing the bone metabolism
induced by this kind of appliance. Kuncio et al.2
suggested that teeth moved with aligners did not
undergo the typical stages of movement, as described
by Krishnan and Davidovitch,3 because of the intermit-
tent forces applied by the aligners. However, light,
continuous forces seem to be perceived as intermittent
forces by the periodontium due to its viscoelastic
nature4 and orthodontic intermittent forces are able to
produce orthodontic tooth movement (OTM) with less
cell damage in the periodontium.5
The inflammatory response to OTM is associated
with the production and release of a variety of
cytokines. Some of these cytokines, including trans-
forming growth factor beta (TGF- b) and interleukin 1
beta (IL-1b), stimulate osteoclast differentiation, func-
tion, and survival, contributing to the bone remodeling
mechanism and tooth movement.6,7 Stimulation of the
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bone cells is mediated by several factors, including a
member of the tumor necrosis factor (TNF) ligand and
receptor superfamilies, including the receptor activator
of nuclear factor kappa B ligand (RANKL), the receptor
activator of nuclear factor kappa B (RANK), and
osteoprotegerin (OPG).8–11 Osteopontin (OPN) is an-
other protein that has been linked to bone resorption
via promotion of osteoclast adhesion to the osseous
matrix.12
Gingival crevicular fluid (GCF) is the medium used to
detect molecules involved in bone modeling and
remodeling processes during OTM.13–17 However, no
data are available in relation to aligner orthodontics.
This is the reason we decided to conduct a
prospective, split-mouth study to measure the concen-
tration of IL-1b, RANKL, OPG, OPN, and TGF b1 in
GCF volumes obtained from teeth subjected to early




Participants were recruited from the Department of
Orthodontics of the CIR Dental School of the University
of Torino during the period March–September 2015.
Eligibility for inclusion in the study were (1) .18 years
of age, (2) good health status, (3) previous extraction of
maxillary third molars, (4) bilateral end-to-end Class II
molar relationship, (5) mesodivergent craniofacial
typology (SpP-GoGn angle ¼ 258 6 68), (6) good
control of oral hygiene, (7) no anti-inflammatory or
antibiotic therapy in the previous 6 months. Exclusion
criteria were (1) smoking habit and (2) signs of
gingivitis or periodontitis.
A total of 10 healthy, adult patients for which
orthodontic treatment with aligners was programmed
(5 men, 5 women, age [mean 6 SD] 22.3 6 3.3) were
selected to participate in this split-mouth study. For
each subject, one second molar was randomly
selected as a test tooth, and the contralateral molar
served as control.
Informed consent was obtained from each subject.
The study was conducted in accordance with the
Declaration of Helsinki, and the research protocol was
approved by the local ethics board (No. 3732015, CIR
Dental School, Turin University).
Intervention
The standardized orthodontic intervention was
represented by the Invisalign (Align Technology,
San Jose, Calif) orthodontic appliance. Using Clin-
Check software (Align Technology) the treatment was
planned to distalize only a randomly selected second
molar in isolation at the beginning of treatment. All the
treatment plans were designed by the same operator
and staging was set at 0.25 mm per aligner.16 The
study lasted for 3 weeks, during which the investi-
gated subjects used only the first aligner planned with
only one movement, that is, distalization of one
second molar. A recent study17 demonstrated that
forces released by the aligner decay over time
without any evidence of affecting the efficiency of
tooth movement.
Attachments were not programmed for the first
aligner. In accordance with the existing literature, the
initial distalizing force was 1 N.18 Two weeks before
beginning the study, all the subjects underwent a
supragingival prophylaxis and were given oral hygiene
instructions to follow at home to eliminate inflammation.
The study lasted for 21 days and involved three visits.
At the first visit (baseline), the Silness and Loe Plaque
(PI) Index, Lobene Modified Gingival Index (GI), and
Bleeding on Probing (BOP) Index were recorded for
the control and for the test molar. The BOP Index was
evaluated after GCF sampling to avoid possible
variations. GCF samples were thus obtained from the
mesiobuccal and distobuccal aspects of both the test
tooth and control tooth. The Invisalign aligner was then
delivered, and proper instructions were provided the
patient. Compliance indicators embedded in each
posterior segment of the maxillary aligner were
monitored during the study.19 Clinical measurements
were then repeated after 1 hour, 7 days, and 21 days
after appliance delivery. GCF samples were obtained
from the mesiobuccal (tension) site and distobuccal
(pressure) site of the test and control molars at each
visit. All samples were collected by the same operator
(EFG).
CGF Sampling
GCF samples were collected 1 hour before appli-
ance placement (T0), 1 hour after aligner delivery (T1),
7 days after (T2), and 21 days after (T3). Days 7 and
21 were chosen for GCF sampling because day 7 is
the turnover time for enzymes and indirect resorption
processes start on day 21.20 Two GCF samples for
each site were collected using PerioPaper strips
(Oraflow Inc, Plainview, NY). Teeth were isolated with
cotton rolls, cleaned of plaque deposits, and dried
gently with air before paper strips were applied 1 mm
subgingivally for 30 seconds. The volume of the
sample on the paper strips was measured using a
calibrated Periotron 8000 (OraFlow). The readings
from the Periotron were converted to an actual volume
(microliters) by reference to the standard curve
calibrated with human serum.21 The GCF absorbed
on each paper point was diluted with 250 lL of sterile
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phosphate-buffered saline (pH 7.4), centrifuged
(13,000 g at 48C for 15 minutes), and stored at 808C
until analysis.22 The Periotron was always calibrated
before GCF sampling.21
Biochemical Analysis
The biologist at the Biochemistry Lab of the
Department of Orthodontics of the University of Torino
performing GCF cytokine measurement was blinded to
the patients’ clinical details. After thawing at room
temperature, stored GCF samples were assayed in
duplicate for IL-1b (Diaclone SAS, Besancon, France),
RANKL (Biomedica Immunoassay GmbH & Co,
Vienna, Austria), OPG (Biomedica), OPN (IBL Interna-
tional, Hamburg GmbH, Germany), and TGF b1
(Diaclone) by enzyme-linked immunosorbent assay
according to the manufacturer’s instructions. Optical
density (OD) was measured on a plate reader using
450 nm wavelength. Since OD is directly proportional
to cytokine concentration, a standard curve generated
from the OD values of standards provided by the
manufacturer was used to determine cytokine concen-
tration. The given concentrations from duplicate
measurements were combined, and mean cytokine
concentration was converted into total cytokine amount
per 250 lL of sample. Finally, cytokine concentration in
the GCF was calculated by dividing the total cytokine
amount by GCF volume (lL) adsorbed on a Perio-
Paper strip.
Statistical Analysis
Statistical analysis was performed using MedCalc
software, version 12.7.0.0 (MedCalc, Ostend, Bel-
gium). Cytokine levels were expressed as mean 6
standard deviation (SD). Data normality was checked
using the D’Agostino-Pearson test. In order to analyze
longitudinal variations of cytokine levels (kinetics)
within groups (intragroup analysis) and to compare
those variations between groups (intergroup analy-
sis), repeated measures analysis of variance (AN-
OVA) was performed. Grouping variables were
appliance of orthodontic force (test sites vs control
sites) and GCF sampling site (mesiobuccal sites vs
distobuccal sites). Paired t-tests were used to
compare cytokine levels at the different time points
in which samples were taken from the patients,
between and within groups. A P value of ,.05 was
considered statistically significant.
RESULTS
No significant differences were detected for the
considered periodontal indexes (PI, GI, or BOP) at any
time point for either test or control teeth (PI tests vs
controls, P¼ .259; GI tests vs controls, P¼ .259; BOP
tests vs controls, P ¼ .500). According to Tuncay et
al.,19 compliance indicators revealed a mean wearing
time of about 22 hours per day.
While GCF volumes did not differ either between or
within test sites or control sites at any time point (Table
1), significant differences were revealed for several
markers when comparing test vs control teeth (Tables
2 and 3; Figure 1).
The ANOVA test for repeated measures resulted in
significant variations in cytokine kinetics within and
between the considered groups, respectively (Table 4).
When considering pressure and tension sampling
sites, IL-1b showed a significant increase at the
pressure sites after 1 week and after 3 weeks with
respect to baseline (P , .05; Figure 2). Intergroup
longitudinal analysis revealed significant differences at
both pressure (P ¼ .007) and tension sites (P ¼ .03;
Table 5).
The kinetics of TGF-1b and OPN were characterized
by a significant increase at the tension sites of the test
teeth (P , .05) after 3weeks from the application of
orthodontic force. The intergroup longitudinal analysis
revealed significant differences at tension sites (P ¼
.003 and P ¼ .001, respectively; Table 5). OPG was
significantly decreased at the pressure and tension
tests sites after 1 week and 3 weeks with respect to
baseline (P ¼ .018 and .047, respectively).
RANKL level was significantly increased at pressure
and tension sites after 1 hour and 1 week from the
application of orthodontic force (P ¼ .023 and .043,
respectively). The intergroup longitudinal analysis
conducted about RANKL concentration revealed sig-
nificant differences at the pressure sites (P ¼ .014;
Table 5).
DISCUSSION
In recent years, aligner orthodontics has grown
rapidly as an increasing number of patients have
sought an esthetic and comfortable alternative to fixed
appliances.23 The results of the present study repre-
sent the first attempt to clarify the biological mecha-
nisms behind aligner orthodontics.
The existing literature demonstrated that interleukin-
1 (IL-1) and tumor necrosis factor alpha (TNF-a) are
proinflammatory cytokines involved in alveolar bone
remodeling following force application.10,24 While GCF
volumes did not differ between or within test sites and
control sites as previously described in the literature,13
interestingly, a significant increase of IL-1b in the GCF
samples of test teeth with respect to those obtained
from the control teeth was observed in this study.
Furthermore, when considering GCF samples obtained
from pressure and tension sites, an increased level of
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1b was evident at the pressure sites. This increase was
statistically significant with respect to levels detected at
the tension sites. Thus, our results are in agreement
with previous in vivo studies demonstrating an asso-
ciation between GCF IL-1b levels and OTM.3,6
TGF-1b is one of the key cytokines with pleiotropic
properties that has both proinflammatory and anti-
inflammatory features in the regulation of the inflam-
matory infiltrate.24 After 3 weeks of aligner therapy, our
results showed an increased level of this cytokine at
the tension sites of the test teeth. TGF-1b plays a role
in bone destruction; however, an increased concen-
tration of this marker has been demonstrated at both
tension and compression sites, revealing a complex
role of this mediator.25
Bone remodeling is controlled by a balance
between RANK-RANKL binding and OPG produc-
tion.25,26 Numerous studies have demonstrated that
the RANK signaling pathway is crucial for differenti-
ating and activating osteoclasts.26 Osteoprotegerin
(OPG) is expressed in osteoblastic cells as well as
RANKL, and it is a decoy receptor produced by
osteoblastic cells, which compete with RANK for
RANKL binding.25
Increased RANKL and decreased OPG secretions
in human PDL cells were demonstrated as a
consequence of compressive forces, and these
Table 1. GCF Volumes in Tension (M) and Compression Sites (D)













(lL) T0 0.17 6 0.07b 0.17 6 0.08 0.19 6 0.08 0.16 6 0.08
GCF T1 0.16 6 0.06 0.23 6 0.10 0.18 6 0.09 0.18 6 0.08
GCF T2 0.18 6 0.07 0.18 6 0.07 0.18 6 0.10 0.16 6 0.10
GCF T3 0.15 6 0.05 0.19 6 0.08 0.15 6 0.06 0.15 6 0.07
a GCF indicates gingival crevicular fluid.
b All variables are expressed as mean 6 standard deviation.
Table 2. Cytokine Comparison Between Test Sites and Control
Sites According to Time Point Sampling
Cytokine
Time
Point Test Sites Control Sites P
IL-1ba (pg/lL) T0 34.9 6 17.5b 36.4 6 13.2 .630
IL-1b T1 32.7 6 23.0 29.7 6 13.3 .649
IL-1b T2 45.7 6 30.9 35.9 6 11.2 .204
IL-1b T3 62.7 6 32.9 31.6 6 11.4 .002
TGF-b1 (pg/lL) T0 62.0 6 26.1 79.7 6 25.7 .189
TGF-b1 T1 80.9 6 26.6 76.5 6 28.3 .425
TGF-b1 T2 74.8 6 25.5 85.8 6 26.3 .224
TGF-b1 T3 118.7 6 43.8 84.2 6 38.4 .085
OPG (pg/lL) T0 4.2 6 2.0 4.4 6 3.5 .810
OPG T1 3.4 6 2.5 4.7 6 3.1 .129
OPG T2 2.2 6 1.9 4.3 6 2.7 .011
OPG T3 2.5 6 2.0 5.6 6 4.5 .039
OPN (ng/lL) T0 28.1 6 15.5 31.2 6 15.7 .426
OPN T1 35.6 6 19.9 26.2 6 13.6 .177
OPN T2 35.2 6 18.5 32.9 6 14.5 .695
OPN T3 46.0 6 22.7 31.3 6 14.7 .054
RANKL (pg/lL) T0 0.5 6 0.4 0.7 6 0.5 .218
RANKL T1 1.2 6 0.8 0.8 6 0.7 .004
RANKL T2 1.3 6 0.9 0.8 6 0.4 .066
RANKL T3 2.5 6 2.2 0.9 6 0.7 .041
a IL-1b indicates interleukin-1 beta; OPG, osteoprotegerin; OPN,
osteopontin; RANKL, receptor activator of nuclear factor kappa B
ligand; TGF-b1, transforming growth factor-beta 1.
b All variables are expressed as mean 6 standard deviation. P
values were evaluated by paired t-tests.
Table 3. Cytokine Levels Compared Between Different Time Points
According to Test Sites and Control Sites
IL-1ba TGF-b1 OPG OPN RANKL
Test sites (pg/lL)
T0 vs T1 0.759 0.124 0.389 0.063 0.008
T0 vs T2 0.244 0.271 0.007 0.128 0.023
T0 vs T3 0.011 0.001 0.047 ,0.001 ,0.001
T1 vs T2 0.203 0.511 0.151 0.927 0.893
T1 vs T3 0.007 0.004 0.184 0.021 ,0.001
T2 vs T3 0.007 0.011 0.490 0.013 ,0.001
Control sites (pg/lL)
T0 vs T1 0.056 0.579 0.512 0.150 0.598
T0 vs T2 0.861 0.088 0.855 0.666 0.201
T0 vs T3 0.218 0.618 0.247 0.497 0.977
T1 vs T2 0.100 0.091 0.512 0.101 0.799
T1 vs T3 0.659 0.521 0.392 0.166 0.286
T2 vs T3 0.248 0.858 0.312 0.755 0.682
a IL-1b indicated interleukin-1 beta; OPG, osteoprotegerin; OPN,
osteopontin; RANKL, receptor activator of nuclear factor kappa B
ligand; TGF-b1, transforming growth factor-beta 1. P values were
evaluated by paired t-tests.
Table 4. Intragroup and Intergroup Longitudinal Analysis in Test






Test sites P ¼ .011 P ¼ .008
Control sites P ¼ .190
TGF-b1 (pg/lL)
Test sites P , .001 P ¼ .001
Control sites P ¼ .499
OPG (pg/lL)
Test sites P ¼ .044 P ¼ .078
Control sites P ¼ .373
OPN (pg/lL)
Test sites P ¼ .001 P ¼ .013
Control sites P ¼ .355
RANKL (pg/lL)
Test sites P ¼ .001 P ¼ .032
Control sites P ¼ .279
a IL-1b indicates interleukin-1 beta; OPG, osteoprotegerin; OPN,
osteopontin; RANKL, receptor activator of nuclear factor kappa B
ligand; TGF-b1, transforming growth factor-beta 1.
b Cytokine levels variation within groups (intragroup analysis) and
cytokine kinetics comparison between groups (intergroup analysis)
were evaluated by repeated measures ANOVA.
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responses were time- and force-magnitude depen-
dent.8 Our results confirm these observations: at the
compression site, we observed a significant increase
of RANKL and a significant decrease of OP. Barbieri
et al.15 described a significant difference for RANK
concentration after 1 day of force delivery (elastic
separator) at pressure sites, differences that were not
detected after 7 days, concluding that RANK may
have a short- term role in bone changes. Our results
demonstrated an increase of RANKL after 1 hour and
1 week of force delivery, confirming the role of the
RANK/RANKL/OPG system in the early stages of
orthodontic treatment. When comparing test sites vs
control sites, we noted that a significantly increased
concentration of RANKL in test sampling sites was
still evident after 3 weeks of force delivery.
Osteopontin (OPN), one of the major noncollage-
nous bone proteins, acts not only as a trigger for
osteoblast early differentiation, but it can also inhibit
osteoclastic activity.26 According to these observations,
Figure 1. IL-1b (A), TGF-1b (B), OPG (C), OPN (D), and RANKL (E) kinetics in test sites and control sites. * Difference between test sites and
control sites at a corresponding time point is statistically significant (P , .05). P values were evaluated by paired t-tests.Cytokine values are
depicted as mean 6 standard deviation.
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results from the present study support a significant
increase of OPN concentration in the GCF samples
obtained from the tension sites of the test teeth after 3
weeks of force delivery.
Caution should be always taken when analyzing
cytokines in GCF samples because of the possibility
of increased secretion due to periodontal plaque-
related inflammation. Although elevated levels of
cytokines have been related to periodontal disease,
the increased concentrations of IL-1b and TNF-a
family cytokines observed in this study are below
those of patients with gingivitis or periodontitis.
Furthermore, periodontal indexes did not change
during the study period, indicating absence of
periodontal inflammation. Therefore, the increased
cytokines levels measured in this study are within the
limits of an acceptable physiological response. The
observed differences can be attributed solely to the
Figure 2. IL-1b (A), TGF-1b (B), OPG (C), OPN (D), and RANKL (E) kinetics according to tension (M) and compression sites (D) (test sites) and
mesiobuccal (M) and distobuccal sites (D) (control sites). * Difference between test sites M and control sites M at corresponding time point is
statistically significant (P, .05). P values were evaluated by paired t-tests. ** Difference between test sites D and control sites D at corresponding
time point is statistically significant (P , .05). P values were evaluated by paired t-tests. Cytokine values are depicted as mean 6 standard
deviation.
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induced orthodontic tooth movement. The use of the
split-mouth design and the results achieved on the
control sites support these considerations. When one
considers the wide range of biological responses and
interfering factors in both the PDL and GCF,27 the
number of subjects participating in this study may be a
limiting factor.
A limitation of this study was the absence of an
internal error method analysis for GCF sampling and
quantification. To overcome this limitation, we calibrat-
ed the Periotron before each GCF sampling.21
In conclusion, aligners seem to be capable of
inducing the same biological responses described for
other appliances, at least in the very early stages of
orthodontic treatment.
CONCLUSIONS
 Invisalign aligners release an initial force of about 1 N
on distalizing a maxillary molar. This force delivery
produces an increased concentration of bone mod-
eling and remodeling mediators at both pressure
sites (IL-1b, RANKL) and tension sites (TGF-1b,
OPN).
 These scenarios are compatible with previous in vivo
and in vitro studies investigating the biological effects
of OTM.
 Further studies are required to elucidate aligners’
OTM effects on longer observation periods.
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